A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy
Clinical trial NCT02365649 · COMPLETED
Trial details
- NCT number
- NCT02365649
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-17
- Primary completion
- 2016-11-25
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.